Development of peptone-based serum-free media to support Vero CCL-81 cell proliferation and optimize SARS-CoV2 viral production.

Publication date: Dec 30, 2024

Concepts Keywords
81cells COVID-19
Fda Manufacture process
Medicines Protein hydrolysate
Survival Serum-free media
Virus Vaccine

Semantics

Type Source Name
drug DRUGBANK Cefaclor
disease IDO production
disease IDO cell
disease IDO protein
disease IDO assay
disease MESH COVID-19
disease IDO process

Original Article

(Visited 1 times, 1 visits today)